Sinopharm’s NVSI-06-07 protein-based vaccine was approved for emergency use as a booster in the United Arab Emirates in December. Photo: Shutterstock
Sinopharm’s NVSI-06-07 protein-based vaccine was approved for emergency use as a booster in the United Arab Emirates in December. Photo: Shutterstock

Sinopharm protein-based booster stronger against Omicron than earlier shot

  • Newer formula induces greater antibody response in people given two doses of the original, researchers say in non-peer-reviewed paper
  • Study authors caution that it’s still not clear how long the effects of the boosters will last

Topic |   Chinese coronavirus vaccines
Sinopharm’s NVSI-06-07 protein-based vaccine was approved for emergency use as a booster in the United Arab Emirates in December. Photo: Shutterstock
Sinopharm’s NVSI-06-07 protein-based vaccine was approved for emergency use as a booster in the United Arab Emirates in December. Photo: Shutterstock
READ FULL ARTICLE